Special Issue Information:
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood-brain barrier (BBB) significantly complicates drug delivery to the target cells in the brain tissues. This proposal describes the current pharmacotherapeutic approaches to treating mental illnesses as well as drug delivery approaches that have improved existing therapies. Approaches to improve drug bioavailability, provide controlled release of therapeutics, and enable drug targeting to the central nervous system (CNS) will be highlighted.
Co-Guest Editor(s):
Dr. Sunil Kumar Kadiri,Dr. Pratap Kumar Sahu
